This paper describes the testicular cancer trends for incidence, survival, socio-economic status (SES) disparities and second cancer occurrence in Geneva, Switzerland, a high-risk population
Testicular cancer (TCa) has a relatively rare incidence and mortality, but has not been thoroughly e...
The aim of this study is to study a possible social gradient for testicular cancer in Norway, and as...
Testicular cancer represents 1%-1.5% of male neoplasms and 5% of urologic tumors in general, with 3-...
Item does not contain fulltextAbstract Background. Worldwide marked changes have been observed in th...
Testicular cancer survival rates improved dramatically after cisplatin-based therapy was introduced ...
We provide updated estimates of survival, incidence, complete prevalence, and proportion cured for p...
The aim of our study was to interpret the changing incidence, and to describe the mortality of patie...
Testicular cancer is a relatively rare dis-ease, accounting for only 1.1 % of all malig-nant neoplas...
BACKGROUND: Testicular cancer is a common malignancy among young males in western countries. OBJECTI...
This article presents a detailed analysis of the incidence trends of testicular cancer and prostate ...
Contains fulltext : 53525.pdf (publisher's version ) (Closed access)The aim of thi...
We provide updated estimates of survival, incidence, complete prevalence, and proportion cured for p...
The aim of our study was to interpret the changing incidence, and to describe the mortality of patie...
This article presents a detailed analysis of the incidence trends of testicular cancer and prostate ...
Background: For unknown reasons, the age-standardized in-cidence of testicular cancer has shown a ra...
Testicular cancer (TCa) has a relatively rare incidence and mortality, but has not been thoroughly e...
The aim of this study is to study a possible social gradient for testicular cancer in Norway, and as...
Testicular cancer represents 1%-1.5% of male neoplasms and 5% of urologic tumors in general, with 3-...
Item does not contain fulltextAbstract Background. Worldwide marked changes have been observed in th...
Testicular cancer survival rates improved dramatically after cisplatin-based therapy was introduced ...
We provide updated estimates of survival, incidence, complete prevalence, and proportion cured for p...
The aim of our study was to interpret the changing incidence, and to describe the mortality of patie...
Testicular cancer is a relatively rare dis-ease, accounting for only 1.1 % of all malig-nant neoplas...
BACKGROUND: Testicular cancer is a common malignancy among young males in western countries. OBJECTI...
This article presents a detailed analysis of the incidence trends of testicular cancer and prostate ...
Contains fulltext : 53525.pdf (publisher's version ) (Closed access)The aim of thi...
We provide updated estimates of survival, incidence, complete prevalence, and proportion cured for p...
The aim of our study was to interpret the changing incidence, and to describe the mortality of patie...
This article presents a detailed analysis of the incidence trends of testicular cancer and prostate ...
Background: For unknown reasons, the age-standardized in-cidence of testicular cancer has shown a ra...
Testicular cancer (TCa) has a relatively rare incidence and mortality, but has not been thoroughly e...
The aim of this study is to study a possible social gradient for testicular cancer in Norway, and as...
Testicular cancer represents 1%-1.5% of male neoplasms and 5% of urologic tumors in general, with 3-...
DOI
Add to ORKG